News & Videos - AXOGEN INC.

Thinking about buying stock in Avalo Therapeutics, AxoGen, Ocugen, BioNano Genomics, or Aurora Innovation? PR Newswire NEW YORK, Jan. 12, 2022 NEW YORK , Jan. 12, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVTX, AXGN, OCGN, BNGO, and AUR. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AVTX:...

...

Scott+Scott Attorneys at Law LLP Investigating Axogen, Inc.'s Directors and Officers for Breach of Fiduciary Duties - AXGN PR Newswire NEW YORK, Oct. 3, 2019 NEW YORK , Oct. 3, 2019 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Axogen, Inc. ("Axogen") (NASDAQ: AXGN) breached their fiduciary duties to Axogen and its shareholders. If you are an Axogen...

(AXGN) Alert: Johnson Fistel, LLP Announces Investigation of AxoGen, Inc.; Long Term Investors Encouraged to Contact Firm PR Newswire SAN DIEGO, July 26, 2019 SAN DIEGO , July 26, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by AxoGen, Inc. ("AxoGen") (NASDAQ: AXGN) and certain of its officers. Earlier in 2019 a securities class action lawsuit was filed against AxoGen, certain of its directors and officers...

AXOGEN EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against AxoGen, Inc. -- AXGN PR Newswire NEW YORK, March 2, 2019 NEW YORK , March 2, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of AxoGen, Inc. (NASDAQ: AXGN): (1) pursuant and/or traceable to the false and/or misleading registration statement and prospectus issued in connection with AxoGen's...

AXGN CLASS ACTION REMINDER: Hagens Berman Reminds AxoGen (NASDAQ: AXGN) Investors of March 11, 2019 Lead Plaintiff Deadline and Possible Accounting Irregularities PR Newswire SAN FRANCISCO, Feb. 26, 2019 SAN FRANCISCO , Feb. 26, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP reminds investors in Axogen, Inc. (NASDAQ: AXGN) of the March 11, 2019 Lead Plaintiff deadline in the pending securities class action. If you purchased or otherwise acquired AxoGen securities between August 7, 2017 and...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AxoGen, Inc. (NASDAQ:AXGN): (1) pursuant and/or traceable to the false and/or misleading registration statement and prospectus issued in connection with AxoGen’s November 2017 secondary public offering; and/or (2) purchased or otherwise acquired AxoGen securities pursuant and/or traceable to AxoGen’s false and/or misleading registration statement and prospectus issued in connection with AxoGen’s May...

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 11, 2019 to file lead plaintiff applications in a securities class action lawsuit against AxoGen, Inc. (NasdaqCM: AXGN), if they purchased the Company’s securities in connection with its November 2017 or May 2018 secondary public offering or between August 7, 2017 and December 18, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle...

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of AxoGen, Inc. (NASDAQ: AXGN): (1) pursuant and/or traceable to the false and/or misleading registration statement and prospectus issued in connection with AxoGen’s November 2017 secondary public offering; and/or (2) purchased or otherwise acquired AxoGen securities pursuant and/or traceable to AxoGen’s false and/or misleading registration statement and...

AXOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AxoGen, Inc. - AXGN PR Newswire NEW ORLEANS, Feb. 8, 2019 NEW ORLEANS , Feb. 8, 2019 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 11, 2019 to file lead plaintiff applications in a securities class action lawsuit against AxoGen, Inc. (NasdaqCM: AXGN), if they purchased the Company's...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In AxoGen, Inc. To Contact The Firm PR Newswire NEW YORK, Feb. 5, 2019 NEW YORK , Feb. 5, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ:AXGN) of the March 11, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the...

RM LAW Announces Class Action Lawsuit Against AxoGen, Inc. PR Newswire BERWYN, Pa., Jan. 24, 2019 BERWYN, Pa. , Jan. 24, 2019 /PRNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ: AXGN) on behalf of purchasers of AxoGen securities: 1) pursuant and/or traceable to the November 2017 SPO; and/or 2) pursuant and/or traceable to the May 2018 SPO; and/or 3) between August...

AXOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AxoGen, Inc. - AXGN PR Newswire NEW ORLEANS, Jan. 18, 2019 NEW ORLEANS , Jan. 18, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have until March 11, 2019 to file lead plaintiff applications...

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against AxoGen, Inc. - AXGN PR Newswire RADNOR, Pa., Jan. 16, 2019 RADNOR, Pa. , Jan. 16, 2019 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against AxoGen, Inc. (Nasdaq: AXGN) ("AxoGen") on behalf of purchasers of AxoGen securities: 1) pursuant and/or traceable to the November 2017 SPO; and/or 2) pursuant and/or traceable to...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AxoGen, Inc. - AXGN PR Newswire NEW YORK, Jan. 11, 2019 NEW YORK , Jan. 11, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AxoGen, Inc. ("AxoGen or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether AxoGen and certain of its officers and/or...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AxoGen, Inc. - AXGN PR Newswire NEW YORK, Jan. 11, 2019 NEW YORK , Jan. 11, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AxoGen, Inc. ("AxoGen or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980. The investigation concerns whether AxoGen and certain of its officers and/or...

Investor Alert: Kaplan Fox Announces Investigation Of AxoGen, Inc. PR Newswire NEW YORK, Jan. 11, 2019 NEW YORK , Jan. 11, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ: AXGN), a company that purports to provide surgical solutions for physical damage or discontinuity to peripheral nerves. AxoGen's products include nerve allografts and extracellular matrices. Investors who...

AxoGen Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Axogen, Inc. - AXGN PR Newswire NEW YORK, Jan. 10, 2019 NEW YORK , Jan. 10, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ: AXGN): (1) pursuant and/or...

AXOGEN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates AxoGen, Inc. for Possible Securities Fraud - AXGN PR Newswire NEW ORLEANS, Dec. 28, 2018 NEW ORLEANS , Dec. 28, 2018 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into AxoGen, Inc. (NasdaqCM: AXGN). On December 18, 2018 , Seligman Investments...

AxoGen Losses Alert: Bernstein Liebhard LLP Announces First Investigation Of AxoGen, Inc. - AXGN PR Newswire NEW YORK, Dec. 20, 2018 NEW YORK , Dec. 20, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of AxoGen, Inc. ("AxoGen" or the "Company") (NASDAQ: AXGN) resulting from allegations that AxoGen and/or its executives may have issued materially misleading business...